Pharmaceutical News

RSS

Research findings could lead to development of new drugs for gout treatment

Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout.

20 Mar 2013

Viewpoints: Protect the FDA's regulatory efforts; Generic drug 'shenanigans;' Does Ryan not understand the 2012 election?

On Tuesday, the Supreme Court will hear arguments in Mutual Pharmaceutical v. Bartlett, a case about the ability of consumers to bring lawsuits against the makers of generic drugs.

20 Mar 2013

Spending on prescription drugs dropped slightly in 2012

The decrease was miniscule, but it was the first time since 1957 that the research firm IMS Health had recorded a dip in United States drug expenditures, reports The New York Times. In related news, more effective use of medications could lead to Medicare savings, according to the Congressional Budget Office.

20 Mar 2013

Large population of healthy people take Aspirin to prevent cardiovascular disease: Study

A new study out of the Faculty of Medicine & Dentistry shows a large population of healthy people are taking Aspirin to prevent cardiovascular disease, despite the fact that new literature shows it isn't as beneficial as once thought.

20 Mar 2013

Study: Propofol addiction is a debilitating form of substance dependence

Abuse of the anesthesia drug propofol is a "rapidly progressive form of substance dependence" that is being more commonly seen among health care professionals, reports a study in the April Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

19 Mar 2013

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

19 Mar 2013

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Mylan Inc. today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate).

19 Mar 2013

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

19 Mar 2013

FDA alert: All sterile drug products of Med Prep Consulting recalled due to contamination

The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of all products produced by Med Prep Consulting Inc. of Tinton Falls, N.J, a specialty pharmacy licensed by the state of New Jersey.

19 Mar 2013

Generic drugmaker liability question to be argued Tuesday before the High Court

The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drugmakers can be held liable for alleged flaws in the designs of their medications, even though federal law requires generic manufacturers to copy the brand drugmaker's design.

19 Mar 2013

BUSM awarded funding to provide opioid prescribing education to health care providers

Awarded the first of its kind funding to provide FDA-mandated opioid prescribing education, Boston University School of Medicine has launched a program to train health care providers how to safely and effectively manage patients with chronic pain using opioid analgesics.

19 Mar 2013

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego.

18 Mar 2013

2 in 5 parents believe HPV vaccine is unnecessary

A rising percentage of parents say they won't have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations, a study by Mayo Clinic and others shows.

18 Mar 2013

Supreme Court slated to hear legal arguments regarding generic drug liability question

Generic drugs are supposed to be identical to the brand names that preceded them. And by law, they have to have identical warnings and labels.

16 Mar 2013

Study shows promising benefit of combination therapy in CRPC patients

Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.

16 Mar 2013

Eye health can be possible through nutrition and supplements, say experts

Eating healthy can affect more than what the scale says. According to experts at the University of Alabama at Birmingham, it is possible to aid eye health through nutrition and supplements.

16 Mar 2013

Study finds increased use of antipsychotic medication among Medicaid-insured children

A new study from the University of Maryland found that use of antipsychotic drugs from 1997 to 2006 increased 7- to 12-fold in a Medicaid population of about 500,000 children ages two to 17.

16 Mar 2013

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.

15 Mar 2013

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public vaccine financing programs are needed, according to new research from the University of Texas Medical Branch (UTMB).

15 Mar 2013

Case Western Reserve University receives grant to research on glucose-responsive insulin

Case Western Reserve University's School of Medicine has received a nearly $1 million grant from The Leona M. and Harry B. Helmsley Charitable Trust's Type 1 diabetes program.

15 Mar 2013

Pharmaceutical News

Research findings could lead to development of new drugs for gout treatment

Viewpoints: Protect the FDA's regulatory efforts; Generic drug 'shenanigans;' Does Ryan not understand the 2012 election?

Spending on prescription drugs dropped slightly in 2012

Large population of healthy people take Aspirin to prevent cardiovascular disease: Study

Study: Propofol addiction is a debilitating form of substance dependence

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

FDA alert: All sterile drug products of Med Prep Consulting recalled due to contamination

Generic drugmaker liability question to be argued Tuesday before the High Court

BUSM awarded funding to provide opioid prescribing education to health care providers

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

2 in 5 parents believe HPV vaccine is unnecessary

Supreme Court slated to hear legal arguments regarding generic drug liability question

Study shows promising benefit of combination therapy in CRPC patients

Eye health can be possible through nutrition and supplements, say experts

Study finds increased use of antipsychotic medication among Medicaid-insured children

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Case Western Reserve University receives grant to research on glucose-responsive insulin

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News